Maithili Dokuparti
About Maithili Dokuparti
Maithili Dokuparti is an Associate Director of Pharmacovigilance Product Management at ArisGlobal, with extensive experience in clinical operations and medical writing. She holds a PhD in Genetics from Osmania University and has pursued advanced management studies at Great Lakes Institute of Management and Indian Institute of Management, Kozhikode.
Work at ArisGlobal
Maithili Dokuparti has been serving as the Associate Director of Pharmacovigilance Product Management at ArisGlobal since 2017. In this role, she is responsible for overseeing product management related to pharmacovigilance, ensuring compliance with regulatory standards, and enhancing product offerings. Her tenure at ArisGlobal has spanned over seven years, during which she has contributed to various initiatives aimed at improving drug safety and efficacy monitoring.
Previous Experience at Mylan
Prior to her current role, Maithili worked at Mylan as a Senior Manager in Global Clinical Operations for a period of ten months in 2016 to 2017. Based in the Hyderabad Area, India, she was involved in managing clinical operations on a global scale, focusing on the execution and oversight of clinical trials and ensuring adherence to regulatory requirements.
Experience at Novartis
Maithili Dokuparti has five years of experience as a Medical Writer at Novartis Vaccines and Diagnostics from 2009 to 2014. During her time in this position, she was responsible for creating and managing clinical documentation, contributing to the development of vaccine products, and ensuring that all written materials met regulatory standards.
Education and Expertise
Maithili earned her PhD in Genetics from Osmania University, where she studied from 2004 to 2008. She further enhanced her management skills by completing a Post Graduate Program in Management for Executives at the Great Lakes Institute of Management from 2022 to 2023. Additionally, she is currently pursuing Advanced Product Management at the Indian Institute of Management, Kozhikode, which she began in 2022.
Membership at Digital Medicine Society
Since 2021, Maithili has been a member of the Digital Medicine Society (DiMe). In this capacity, she engages with a community focused on advancing digital medicine and improving healthcare through technology. Her involvement reflects her commitment to staying at the forefront of innovations in the medical field.